Results
Eris Lifesciences Q2 FY2027 Net Profit Rises 28% YoY
Board approved unaudited standalone and consolidated financial results for Q2 and H1 FY2027, with the meeting held on October 26, 2026.
Consolidated net profit attributable to owners grew to ₹183.82 C
